Skip to content
The Policy VaultThe Policy Vault

Mekinist (trametinib) — Medica

Histiocytic Neoplasm

Initial criteria

  • Patient has ONE of the following (A, B, or C): A) Langerhans cell histiocytosis; OR B) Erdheim-Chester disease; OR C) Rosai-Dorfman disease

Approval duration

1 year